ACM
EXAS

Atika Capital Management’s Exact Sciences EXAS Stock Holding History

Atika Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-211,120
Closed -$8.92M – 96
2024
Q2 		$8.92M Sell
211,120
-3,880
-2% -$213K 0.87% 39
2024
Q1 		$14.8M Buy
215,000
+93,000
+76% +$5.88M 1.46% 21
2023
Q4 		$9.03M Buy
122,000
+78,000
+177% +$5.11M 1.21% 31
2023
Q3 		$3M Sell
44,000
-199,000
-82% -$16.9M 0.39% 64
2023
Q2 		$22.8M Buy
+243,000
New +$19M 2.28% 10
2021
Q4 		– Sell
-70,000
Closed -$6.68M – 100
2021
Q3 		$6.68M Hold
70,000
– – 0.4% 77
2021
Q2 		$8.7M Hold
70,000
– – 0.69% 57
2021
Q1 		$9.22M Sell
70,000
-32,300
-32% -$4.42M 0.8% 56
2020
Q4 		$13.6M Sell
102,300
-8,900
-8% -$1.08M 1.06% 39
2020
Q3 		$11.3M Buy
111,200
+47,200
+74% +$4.08M 0.93% 39
2020
Q2 		$5.56M Sell
64,000
-17,000
-21% -$1.36M 0.72% 60
2020
Q1 		$4.7M Buy
81,000
+8,500
+12% +$690K 0.9% 36
2019
Q4 		$6.71M Sell
72,500
-27,500
-28% -$2.42M 1.29% 35
2019
Q3 		$9.04M Sell
100,000
-35,300
-26% -$4.02M 1.9% 19
2019
Q2 		$16M Sell
135,300
-22,700
-14% -$2.29M 3.14% 4
2019
Q1 		$13.7M Buy
158,000
+7,500
+5% +$638K 2.78% 4
2018
Q4 		$9.5M Buy
150,500
+25,500
+20% +$1.75M 2.8% 6
2018
Q3 		$9.87M Buy
125,000
+7,000
+6% +$456K 1.77% 16
2018
Q2 		$7.05M Buy
118,000
+96,500
+449% +$5.19M 1.36% 21
2018
Q1 		$867K Sell
21,500
-41,500
-66% -$2.02M 0.3% 68
2017
Q4 		$3.31M Sell
63,000
-27,000
-30% -$1.44M 1.28% 36
2017
Q3 		$4.24M Sell
90,000
-946
-1% -$38.1K 1.22% 23
2017
Q2 		$3.22M Buy
+90,946
New +$2.81M 1.13% 30
2016
Q4 		– Sell
-148,300
Closed -$2.75M – 65
2016
Q3 		$2.75M Buy
+148,300
New +$2.61M 1.12% 34

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Atika Capital Management's EXAS Position: Q3 2024 in Review

Atika Capital Management sold out of Exact Sciences (EXAS) in Q3 2024, closing a stake of 211,120 shares — an estimated $8.92M sold.

Atika Capital Management first reported a position in EXAS in Q3 2016 and held it in 24 quarters. The position peaked at $22.8M in Q2 2023. 598 funds tracked by Wall St. Rank hold EXAS as of Q3 2024.

  • Atika Capital Management reported no remaining Exact Sciences position as of Q3 2024 after selling out during the quarter.
  • Atika Capital Management sold 211,120 Exact Sciences shares in Q3 2024, an estimated $8.92M.
  • Atika Capital Management first reported a position in Exact Sciences in Q3 2016 and held it in 24 quarters.
  • Atika Capital Management's Exact Sciences position peaked at $22.8M in Q2 2023.
  • 598 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2024.

Based on Atika Capital Management's 13F filing for Q3 2024, filed 13 Nov 2024.